Lundergan C F, Ross A M, McCarthy W F, Reiner J S, Boyle D, Fink C, Califf R M, Topol E J, Simoons M L, Van Den Brand M, Van de Werf F, Coyne K S
Cardiovascular Research Institute and the GUSTO-I Core Angiographic Laboratory, George Washington University, Washington, DC, USA.
Am Heart J. 2001 Jul;142(1):43-50. doi: 10.1067/mhj.2001.116076.
Despite the significant survival benefit associated with successful reperfusion therapy for acute myocardial infarction, global indices of outcome left ventricular function, such as ejection fraction, have often demonstrated little or no improvement. Although these measurements are confounded by numerous clinical, physiologic, and angiographic variables, no comprehensive analysis of this issue in a large series of patients is available. We used the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) database to better understand this phenomenon by determining independent predictors of left ventricular function and their interplay with regard to outcome ventricular function and improvement in function during the initial postinfarction week.
Ninety-minute and 5- to 7-day posttreatment global and regional indices derived from left ventriculograms were analyzed from a population of 676 patients. These observations were combined with clinical data to describe independent determinants of ventricular function outcome.
Clinical factors predictive of global and regional ventricular function as well as improvement in function between 90 minutes and 5 to 7 days included time to treatment, early infarct-related artery flow grade, and body mass index. These same factors contribute significantly to compensatory hyperkinesis of the noninfarct zone, which is critical to maintenance of global ventricular function during this time period.
The ventricular function benefits of early complete reperfusion after myocardial infarction are readily demonstrable after adjustment for multiple covariables and include (1) maintenance of global ventricular function and (2) prevention or delay in ventricular dilatation.
尽管急性心肌梗死成功再灌注治疗具有显著的生存获益,但左心室功能等整体预后指标,如射血分数,往往显示改善甚微或没有改善。尽管这些测量受到众多临床、生理和血管造影变量的干扰,但尚无对大量患者中此问题的全面分析。我们利用冠状动脉闭塞时链激酶和组织型纤溶酶原激活剂的全球应用(GUSTO - I)数据库,通过确定左心室功能的独立预测因素及其与预后心室功能以及梗死发生后第一周内功能改善之间的相互作用,来更好地理解这一现象。
对676例患者群体的左心室造影得出的90分钟及治疗后5至7天的整体和局部指标进行分析。将这些观察结果与临床数据相结合,以描述心室功能预后的独立决定因素。
预测整体和局部心室功能以及90分钟至5至7天内功能改善的临床因素包括治疗时间、早期梗死相关动脉血流分级和体重指数。这些相同因素对非梗死区的代偿性运动增强有显著贡献,这在此时间段对维持整体心室功能至关重要。
在对多个协变量进行调整后,心肌梗死后早期完全再灌注对心室功能的益处很容易显现,包括(1)维持整体心室功能和(2)预防或延迟心室扩张。